Results 31 to 40 of about 6,247 (199)

Cardiovascular-Kidney-Metabolic Overlaps, Clinical Outcomes, and Medications Among Patients With Heart Failure: Results From the Chinese Cardiovascular Association Database-Heart Failure Center Registry. [PDF]

open access: yesMedComm (2020)
In a nationwide heart failure cohort, cardiovascular–kidney–metabolic (CKM) multimorbidity was common in Chinese hospitalized heart failure (HF) patients and associated with poor prognosis. Higher CKM burden and combinations identified high‐risk patients.
Wang X   +15 more
europepmc   +2 more sources

Editorial: HFpEF and HFmrEF: Different Sides of the Same Coin?

open access: yesFrontiers in Cardiovascular Medicine, 2022
Sin financiación ; 5.848 JCR (2021) Q2, 43/143 Cardiac & Cardiovascular Systems ; 1.443 SJR (2021) Q1, 54/356 Cardiology and Cardiovascular Medicine ; No data IDR 2021 ...
Manuel Martínez-Sellés   +6 more
openaire   +6 more sources

Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI

open access: yesBMC Cardiovascular Disorders, 2022
Background The characteristics of heart failure (HF) with mildly reduced ejection fraction (EF) (HFmrEF) overlap with those of HF with reduced EF (HFrEF) and HF with preserved EF (HFpEF) and need to be further explored.
Yuliang Ma   +9 more
doaj   +1 more source

Heart failure with mid‐range ejection fraction: characterization of patients from the PINNACLE Registry®

open access: yesESC Heart Failure, 2019
Aims Guidelines for management of patients with heart failure with mid‐range ejection fraction [HFmrEF; left ventricular EF (LVEF) 41–49%] do not exist. Disagreement exists whether HFmrEF should be considered a distinct group. The aim of this study is to
Nasrien E. Ibrahim   +7 more
doaj   +1 more source

Sex differences in patients with heart failure and mildly reduced left ventricular ejection fraction

open access: yesScientific Reports, 2023
Clinical studies on heart failure with mildly reduced left ventricular ejection fraction (HFmrEF) have gradually increased. However, studies on the prognostic differences between men and women among patients with HFmrEF are few, and no evidence on sex ...
Zhican Liu   +14 more
doaj   +1 more source

Long‐term mortality in heart failure with mid‐range ejection fraction: systematic review and meta‐analysis

open access: yesESC Heart Failure, 2022
Aims Heart failure patients with mid‐range ejection fraction (HFmrEF) have overlapping clinical features, compared with patients with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF).
Deep Chandh Raja   +10 more
doaj   +1 more source

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides

open access: yesFrontiers in Cardiovascular Medicine, 2021
This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities,
Kaiyuan Zhu   +8 more
doaj   +1 more source

Total Pectoral Muscle Area and Prognostic Nutritional Index Provide Complementary Prognostic Information for Patients Hospitalized with HFmrEF/HFrEF. [PDF]

open access: yesJ Clin Med
Background: Skeletal muscle depletion and malnutrition are common in heart failure (HF) and are associated with poor outcomes. Whether imaging-derived skeletal muscle reserve and laboratory-based nutritional indices provide complementary prognostic ...
Alak Ç   +5 more
europepmc   +2 more sources

Clinical course and risk prediction of permanent atrial fibrillation development in patients with chronic heart failure and mid-range ejection fraction of the left ventricle.

open access: yesMedičnì Perspektivi, 2020
The purpose of the study was to establish clinical features of permanent atrial fibrillation (AF) in patients with heart failure mid-range ejection fraction (HFmrEF) and to develop a mathematical model for predicting arrhythmia development.
O. O. Khaniukov   +3 more
doaj   +1 more source

Coronary Flow in Hypertrophic Obstructive Cardiomyopathy—Immediate Effects of Alcohol Septal Ablation

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Hypertrophic cardiomyopathy is associated with alterations in coronary microvascular function which have variable pathophysiologic mechanisms, and variable reversibility acutely and chronically following alcohol septal ablation (ASA).
Vojko V. Misevic   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy